GlycoMantra has been awarded a two-year SBIR Phase 2 grant ($3.7 M) from the NIDDK…
GlycoMantra will present at the Oncology Investor Conference.
GlycoMantra has been selected to pitch at the NYC Spring Oncology Investor Conference 2020.
Blog